Traws Pharma, Inc. — Director's Dealing 2020

Nov 27, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Onconova Therapeutics, Inc. (ONTX)
CIK: 0001130598
Period of Report: 2020-11-24

Reporting Person: MARINO JAMES J (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-11-24	Common Stock	P	38774	$.258	Acquired	205716	Direct